🇺🇸 FDA
Patent

US 8835386

Activity of recombinant equine follicle stimulating hormone

granted A61KA61K38/00A61P

Quick answer

US patent 8835386 (Activity of recombinant equine follicle stimulating hormone) held by The Regents of the University of California expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P15/00